Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Footer updates include revision note changing to v3.3.3 and removal of the HHS Vulnerability Disclosure link; related topics (MedlinePlus Genetics) were added. Core study details such as condition (Multiple Myeloma), interventions (Nivolumab, Melphalan, autologous stem cell transplantation), and outcomes remain unchanged.
    Difference
    0.3%
    Check dated 2025-12-23T13:26:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The condition 'Multiple Myeloma' and the 'MedlinePlus Genetics' related topic were removed from the page; this reduces contextual clarity and removes a background information resource.
    Difference
    0.2%
    Check dated 2025-12-16T03:27:28.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Related topics section updated to include Multiple Myeloma and MedlinePlus Genetics.
    Difference
    0.2%
    Check dated 2025-12-08T22:44:41.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    An updated revision label v3.3.2 was added and the previous v3.3.1 label was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:24:29.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.3.1 was added. The terms 'Multiple Myeloma' and 'MedlinePlus Genetics' were removed.
    Difference
    0.2%
    Check dated 2025-11-24T14:38:05.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    A site-wide banner warning about a lapse in government funding and potential data updates was removed from this page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:46:04.000Z thumbnail image

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.